Announced Tue, 5 Aug · 15:21 IST

Proceedings of the 36th Annual General Meeting of the Company held on August 5, 2025.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Resonance Specialties Limited held its 36th Annual General Meeting on August 5, 2025 via video conferencing, chaired by Mrs. Archana Yadav. All directors, the CFO, and the Company Secretary were present, along with representatives of the Statutory Auditors, Secretarial Auditors, and Scrutinizer. Key business items included adoption of the audited financial statements for FY ended March 31, 2025, re-appointment of Mr. Prashant Godha as Director (retiring by rotation), and declaration of a dividend of Re. 1 per share (10% on face value of Rs. 10). Special business items covered the appointment of M/s. Alok Khairwar and Associates as Secretarial Auditor for five years from FY 2025-26, approval for related party transactions with Kaygee Laboratories Private Limited up to Rs. 50 crores per financial year, and ratification of remuneration for Cost Auditors M/s Poddar & Co. for FY 2025-26. E-voting was conducted between August 1 and August 4, 2025, with results to be declared after the Scrutinizer's report is received.

Likely market impact

Shareholders benefit from a 10% dividend (Re. 1 per share), while the approval of up to Rs. 50 crore in related party transactions with Kaygee Laboratories is worth monitoring for governance and conflict-of-interest considerations. The meeting outcome is largely procedural with no major strategic surprises.